ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

25,579Medicare Part D Prescriptions Filled, Including Refills

Rank: 23 out of 1000

$1.51M Total Retail Price of All Prescriptions

Rank: 14 out of 1000

877 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
56% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 877 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

28% of this provider’s 877 patients filled at least one prescription for a schedule three drug, compared to an average of 20%.

Risky Drugs to Seniors

2% of this provider’s 18,628 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
HYDROCODONE-ACETAMINOPHEN 1,102 767 S3 1 1
LEVOTHYROXINE SODIUM 887 719 2 4
SIMVASTATIN 723 586 3 3
LISINOPRIL 626 447 4 5
PRAVASTATIN SODIUM 565 439 5 12
OMEPRAZOLE 564 461 6 2
AMLODIPINE BESYLATE 541 423 7 6
METOPROLOL SUCCINATE 490 381 8 21
CITALOPRAM HBR 486 344 9 17
PANTOPRAZOLE SODIUM 471 368 10 28
METFORMIN HCL 455 316 11 8
TRAMADOL HCL 422 302 12 13
FUROSEMIDE 410 337 13 7
POTASSIUM CHLORIDE 369 297 14 10
TAMSULOSIN HCL 345 291 15 33
MELOXICAM 326 245 16 14
CARVEDILOL 325 262 17 15
MIRTAZAPINE 314 241 18 56
METOPROLOL TARTRATE 306 253 19 19
GABAPENTIN 293 202 20 11
ATORVASTATIN CALCIUM 275 205 21 18
DONEPEZIL HCL 269 243 22 32
TORSEMIDE 249 198 23 137
TRAZODONE HCL 243 135 24 29
ZOLPIDEM TARTRATE 239 160 25 16
HYDROCHLOROTHIAZIDE 236 191 26 9
QUETIAPINE FUMARATE 229 178 27 75
WARFARIN SODIUM 224 187 28 22
CRESTOR 222 157 29 30
NEXIUM 205 98 30 23
AMLODIPINE BESYLATE-BENAZEPRIL 196 171 31 59
DIGOXIN 193 165 32 52
ATENOLOL 187 120 33 24
CLONIDINE HCL 184 152 34 27
LISINOPRIL-HYDROCHLOROTHIAZIDE 183 118 35 20
BUMETANIDE 181 131 36 112
CLOPIDOGREL 170 110 37 35
ESCITALOPRAM OXALATE 170 148 37 60
LYRICA 167 119 39 47
NAMENDA 156 145 40 43
PREDNISONE 156 130 40 42
CYMBALTA 149 66 42 53
ALENDRONATE SODIUM 148 136 43 57
ALLOPURINOL 139 114 44 31
SPIRIVA 136 105 45 64
RISPERIDONE 135 90 46 87
LANTUS 129 83 47 68
AMIODARONE HCL 129 104 47 178
GLIMEPIRIDE 129 92 47 34
CARISOPRODOL 127 43 R 50 72
HYDRALAZINE HCL 127 87 50 74
PLAVIX 122 99 52 49
LOSARTAN POTASSIUM 112 92 53 25
TRIAMTERENE-HCTZ 109 78 54 48
SPIRONOLACTONE 108 94 55 78
KLOR-CON M20 106 93 56 66
OLANZAPINE 105 57 57 188
ADVAIR DISKUS 104 94 58 65
DIVALPROEX SODIUM 99 50 59 113
LOVASTATIN 98 59 60 41
CIPROFLOXACIN HCL 97 76 61 46
CELEBREX 94 76 62 98
BYSTOLIC 93 55 63 126
METOCLOPRAMIDE HCL 92 41 64 99
LEVETIRACETAM 91 51 65 128
AGGRENOX 91 86 65 243
VESICARE 89 74 67 200
SEROQUEL 88 71 68 157
SERTRALINE HCL 87 62 69 26
CARBIDOPA-LEVODOPA 87 80 69 116
GLIPIZIDE 86 65 71 62
DIOVAN HCT 83 58 72 96
DIVALPROEX SODIUM ER 83 22 72 184
ISOSORBIDE MONONITRATE ER 79 67 74 71
OXYCODONE-ACETAMINOPHEN 79 62 S2 74 202
KLOR-CON 10 79 45 74 104
DILTIAZEM 24HR ER 78 52 77 189
PHENYTOIN SODIUM EXTENDED 78 65 77 115
OXYCONTIN 77 36 S2 79 166
FOSINOPRIL SODIUM 77 77 79 154
LOSARTAN-HYDROCHLOROTHIAZIDE 77 65 79 38
INSULIN SYRINGE 76 46 82 93
LABETALOL HCL 76 52 82 258
CYCLOBENZAPRINE HCL 75 34 R 84 39
RAMIPRIL 74 39 85 77
SULFAMETHOXAZOLE-TRIMETHOPRIM 71 48 86 70
EXELON 70 51 87 108
ACTOS 70 51 87 119
FINASTERIDE 68 44 89 177
AVODART 68 57 89 214
SYMBICORT 67 49 91 149
GLIPIZIDE ER 67 26 91 106
BENICAR HCT 65 58 93 262
LOVAZA 64 40 94 148
COLCRYS 60 25 95 171
FAMOTIDINE 60 52 95 88
PREMARIN 59 19 R 97 109
BACLOFEN 58 49 98 129
FLUOXETINE HCL 58 38 98 51
METHOCARBAMOL 57 30 R 100 79
EVISTA 56 56 101 168
DILTIAZEM 24HR CD 54 45 102 136
PROMETHAZINE HCL 53 33 R 103 54
OXYBUTYNIN CHLORIDE ER 51 39 104 157
NOVOLOG 51 43 104 156
ENOXAPARIN SODIUM 51 30 104 308
LEXAPRO 51 47 104 196
AZOR 50 34 108 334
MECLIZINE HCL 50 43 108 80
JANUVIA 50 21 108 85
NITROFURANTOIN 50 47 108 199
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 6, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.